Weight-loss jab can cut heart attack and stroke risk in obese adults, firm says

Photo caption: Wegovy weightloss injector pens. The study was announced by Novo Nordisk, rather than in a peer-reviewed research paper, so details were limited. Photo credit: Jim Vondruska / Reuters. Article by Nicola Davis. The Guardian – August 8, 2023.

The weight-loss jab Wegovy can reduce the risk of major cardiovascular events by 20% in people who are overweight or obese, the company behind the drug says. Wegovy – which is not yet available in the UK – has been hailed a wonder drug for weight loss […]

Click here to view original web page at www.theguardian.com